TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Confidence in performing rehabilitation exercises
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motivation to engage in long-term adaptive behaviour change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ED 90 of norepinephrine for preventing hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dexterity performance (NHPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn CRP levels associated with DNA methylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration of castration level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adjusted Adenoma Detection Rate for adenomas <10 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean endpoint change in the PANSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rates for lurasidone vs. placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of SLPI and CLU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of submucosal glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration–time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean terminal elimination half‐life (t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuromuscular test enhancements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patch adhesion ≥ 80% (EMA score 0‐1) at end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA-PFS2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of IOP 30 mm Hg or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean number of days to first IOP response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all-cause death or new-onset HF
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of all-cause death or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: completion times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of initiation of LARC method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of continuation of LARC method
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: MBD (Metabolic Bone Disease) incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HTV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of AKP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic accuracy of mucosa‐associated lymphoid tissue lymphoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anopheline larval densities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %Sedentary (percentage of sedentary behaviour)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in size of keloids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety-numerical rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech sound skills in babble
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expressive vocabularies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global developmental scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent cases of intussusception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean maximum insertion torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean ultimate pull-out strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSDI scores (Ocular Surface Disease Index)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 30-minute modified Aldrete scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyoid bone movement displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharyngeal delivery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to engage in risky behavior facilitating COVID-19 transmission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MRD negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental efficacy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: overall psychosocial adjustment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adherence to exercise intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PFMs function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health knowledge proficiency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: attenuation of bacterial dysbiosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dystonia symptoms improvement (TWSTRS total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot migration leading to inaccessibility
Endpoint domain: Adverse events/effects
Primary endpoint: BCR::ABL1IS response by 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Postoperative neurocognitive dysfunction (PNCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of recovery (QoR-40 scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total taste test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average total plate waste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning outcome score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of practices using the Translating and Interpreting Service (TIS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Three-year overall survival (OS) for patients achieving major volumetric partial response
Endpoint domain: Mortality/survival
Primary endpoint: all-cause mortality or disabling stroke
Endpoint domain: Mortality/survival
Primary endpoint: drinking intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 30-second sit-to-stand test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Up-and-Go test improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness of longstanding exercise therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness of longstanding exercise therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: OHIP-14 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PES/WES scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knowledge of stroke and its risk factors
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Comprehension accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood to recommend test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lumbar bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total alkaline phosphatase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone alkaline phosphatase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: latency to first drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of cough during patient transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in all-cause diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in microbial quality of community and household water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in SHAPS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δbrachial diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Δflow‐mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Δtime to peak diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Progression of diabetic kidney disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Low-Density Lipoprotein of Cholesterol (LDL-c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean scores of learning and knowledge retention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in LCI2·5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in SwCl concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in CFQ-R respiratory domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bioequivalence of apixaban tablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability and safety of apixaban tablets
Endpoint domain: Adverse events/effects
Primary endpoint: Causal association with ANC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Composite of all-cause mortality or non-fatal centrally adjudicated new Q-wave myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Mean pain score at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean NRS change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical improvement by Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in EQ-5D-3L utilities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neurologically favorable survival for 180 days
Endpoint domain: Mortality/survival
Primary endpoint: incidence of unplanned hospital visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: incidence of emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Time <3.9 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NT-pro-BNP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Attitude towards seeking emergent medical attention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central venous pressure during resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total intraoperative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary symptoms and problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adjusted mean change in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rare nonsynonymous variants in the eTLR pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of parasitaemic and afebrile patients at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rate at Day 28 and 42
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in joint scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Number of Adenomas per Patient (MAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: LA reservoir strain (LASr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2-h OGTT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean cost of laparoscopic‐assisted surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perioperative state anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' ratings of VORT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: muscle function recovery duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle IL1R1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: muscle IL1RL1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RMS difference between impressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rate on perampanel at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Median reduction in seizure frequency per 28 days from baseline at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of patients seizure free at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Hepatitis B vaccine response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total sugars intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative maintenance fluid requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h postoperative fluid requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum sodium values at postoperative 12th and 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: forearm circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in lesion extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-operative pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: pain VAS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in body image
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum omentin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: high-density lipoprotein cholesterol (HDL-C) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cost-effectiveness of online support vs onsite support
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: morphine consumption during the first 48 postoperative hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Engagement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in VO2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in waist circumference (WC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of acquiring COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Health behaviours improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient satisfaction (GPE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Selective attention (TMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (intensity level)
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of epileptogenic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity goals achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Health Summary (PHS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Health Summary (MHS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LA mechanics improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aortic distensibility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Aortic stiffness index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IOP elevation more than 10 mm Hg over baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: IOP higher than 35 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: successful lesion crossing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PNIF post-surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of developing dysphonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of having RLNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: complete closure during speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: identification of persistent or recurrent inadequate velum closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective overall image quality of MRI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: eGFR < 60 ml/min/1.73 m2 at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: decreasing eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: quality adjusted survival
Endpoint domain: Mortality/survival
Primary endpoint: risk of dying intervention eligibility criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSH level variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Thinking about health harms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discouragement from wanting to consume sugary drinks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall accuracy of the peanut BBEA diagnostic test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month poor recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of post‐traumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of dissociative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROX index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with breasts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complications within 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Health care cost
Endpoint domain: Resource use
Primary endpoint: Use of intrauterine device at six months after abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Information-processing speed impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual memory impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dose of propofol and remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ability to not let emotions interfere with performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlling attention in training and competition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased experiential avoidance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-month csPCa rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes